Skip to main content
WeightCited

Glutamine per Obesity

C Evidenze Evidenza limitata da studi di piccole dimensioni, ma esistono alcuni segnali positivi.

RCT (n=66) found 30 g/day reduced weight and waist circumference comparably to isonitrogenous protein control. Systematic review of 7 trials found improved inflammatory markers and gut barrier function in obese patients. Evidence is preliminary but growing, with benefits potentially mediated through the gut-metabolic axis.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dglutamine\u0026condition\u003Dobesity'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

In sintesi

RCT (n=66) found 30 g/day reduced weight and waist circumference comparably to isonitrogenous protein control. Systematic review of 7 trials found improved inflammatory markers and gut barrier function in obese patients. Evidence is preliminary but growing, with benefits potentially mediated through the gut-metabolic axis.

Key Study Findings

Other
[Nutrition in the prevention and healing of chronic wounds. Importance in improving the diabetic foot].
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: chronic wounds and have been linked to delayed wound healing and dehiscence

Review
Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: Humans (general)

Review
The Na+/Cl--Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic …
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: Cancer patients (SLC6A14 transporter review)

Key Statistics

7

Studi

300

Partecipanti

Positive

C

Grado

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
5-10 g/day
guthealth:
10-20 g/day
exerciserecovery:
5-10 g pre/post workout

Limite massimo: 40 g/day (well-tolerated in clinical trials)

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Positive --
None -- Mixed --
None -- Mixed --

Momento migliore per l'assunzione: Between meals or pre/post-exercise; may add to protein shakes

Safety & Side Effects

Effetti collaterali segnalati

  • Bloating
  • GI discomfort
  • Constipation

Interazioni note

  • Lactulose (may reduce effectiveness)
  • Anticonvulsants (may reduce effectiveness)

Livello di assunzione massimo tollerabile: 40 g/day (well-tolerated in clinical trials)

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Glutamine help with Obesity?
Based on 7 studies with 300 participants, there is limited but promising evidence that Glutamine may support Obesity management. Our evidence grade is C (Some Evidence).
How much Glutamine should I take for Obesity?
Studies have used various dosages. A commonly studied range is 5-10 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Glutamine?
Reported side effects may include Bloating, GI discomfort, Constipation. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Glutamine and Obesity?
We rate the evidence as Grade C (Some Evidence). This rating is based on 7 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

References

  1. [1] Guoyao Wu et al.. Adv Exp Med Biol. 2021. Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans. doi:10.1007/978-3-030-74180-8_10 PubMed
  2. [2] Rosa María Martínez García et al.. Nutr Hosp. 2021. [Nutrition in the prevention and healing of chronic wounds. Importance in improving the diabetic foot]. doi:10.20960/nh.03800 PubMed
  3. [3] Mohd Omar F Sikder et al.. AAPS J. 2017. The Na+/Cl--Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis. doi:10.1208/s12248-017-0164-7 PubMed

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.